Nektar Therapeutics | NKTR - 贷款资金



金融业
股票价格
USD
资产
USD 763.27M
现金及等价物
USD 149.58M
销售成本
USD 4.44M
流动资产
USD 589.04M
流动负债
USD 57.71M
债务
USD 0
股息收益率
0
EBIT
USD -38.26M
EBITDA
USD -38.9M
员工
137
EPS每股收益
USD -1.78
股本和储备
USD 576.22M
销售毛利
USD 10.86M
债务利息支出
USD 7.94M
利息收入
USD -0.18
贷款资金
USD 60.27M
市值
USD 12.18B
净收入
USD -44.9M
营业费用
USD 49.12M
营业利润
USD -38.26M
普通股股本
USD 29.47M
税前利润
USD -43.09M
销售收入
USD 10.86M
销售和管理费用
USD 11.87M
股票
USD 14.46M
贸易债权人
USD 10.03M
应收帐款人
USD 3.6M


贷款资金 更改 日
Agios Pharmaceuticals USD 1.06M 0 2022-09
ALKERMES USD 1.48B 7.23M 2026-06
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Amgen USD 51.86B 27M 2026-06
Baxter International USD 8.62B 6M 2026-06
BioCryst Pharmaceuticals USD 395.4M 203K 2026-06
Biogen USD 7.29B 1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Cara Therapeutics USD 0 0 2025-03
Cipla INR 3.82B 840.2M 2026-03
Dr.Reddys Laboratories INR 12.2B 595M 2026-03
Eisai JPY 184.6B 49.83B 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
Merck USD 51.08B 4.41B 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Takeda JPY 4.42T 50.32B 2026-06
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06
Xencor USD 77.54M 4.59M 2026-06